Takeda Pharmaceutical Company Limited
ANTIBODY-DRUG CONJUGATES COMPRISING A CYCLIC DINUCLEOTIDE
Last updated:
Abstract:
The present disclosure provides a compound having a STING agonistic activity, which may be expected to be useful as an agent for the prophylaxis or treatment of STING-related diseases. The present disclosure relates to a compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the description, or a salt thereof.
Status:
Application
Type:
Utility
Filling date:
7 Oct 2020
Issue date:
15 Apr 2021